ISRT 2025 -International Symposium on Radiopharmaceutical Therapy
Sponsoring ISRT 2025 in Baku
We’re honored to serve as a Platinum Sponsor of the 2025 International Symposium on Radiopharmaceutical Therapy (ISRT)—a leading academic forum advancing innovation in nuclear medicine.
At Nucs AI, we are redefining prostate cancer care through intelligent imaging. By combining AI-driven quantification and predictive analytics, we’re helping clinicians and researchers unlock new levels of precision in PSMA-PET/CT interpretation.
Meet Us in Baku | April 10–12, 2025
We’ll be showcasing our two flagship solutions:
• DeepPSMA – for automated detection, staging, and quantification of tumor burden
• SelectPSMA – for predicting response to ¹⁷⁷Lu-PSMA-617 therapy in mCRPC patients
Visit our booth to explore how our tools support standardization, research scalability, and clinically meaningful insights across the continuum of prostate cancer care.
Connect with Our Team
To schedule a meeting at ISRT 2025 or speak with us virtually, contact us here. We look forward to thoughtful conversations with the academic community pushing nuclear medicine forward.
